Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cesca Therapeutics Inc (NASDAQ:KOOL)

3.96
Delayed Data
As of Oct 20
 +0.06 / +1.54%
Today’s Change
2.41
Today|||52-Week Range
6.44
+14.78%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$39.4M

Company Description

Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. The Device Division segment includes development and commercialization of automated technologies for cell-based therapeutics and bio-processing. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Contact Information

Cesca Therapeutics, Inc.
2711 Citrus Road
Rancho Cordova California 95742
P:(916) 858-5100
Investor Relations:
(916) 858-5191

Employees

Shareholders

Individual stakeholders70.57%
Other institutional1.62%
Mutual fund holders1.02%

Top Executives

Xiao Chun XuChairman & Chief Executive Officer
Vivian H. LiuChief Operating Officer & Director
Jeffery CaublePrincipal Financial & Accounting Officer
Philip H. CoelhoChief Technology Officer
Dalip SethiSenior Director-Research & Development